Praxis Precision surges on positive ulixacaltamide data for essential tremor, but tolerability limits impact. Explore PRAX's ...

A rush by fund managers to boost portfolios will help take the S&P 500 to 7,000, says Tom Lee The bull will continue to rum, according to Fundstrat. Will it come to be known as the Cockroach Crash!?

FTSE 100 fell 1.6% as US banking worries spread to London. Barclays and Standard Chartered led losses while bonds rallied on ...

Rebecca Maclean, fund manager at Dunedin Income Growth Investment Trust on gold, the stock she'd buy for the next 10 years, ...

Looking to invest in gold without the hassle of storing physical bars or coins? This guide explores five smart alternatives.

The Nasdaq Composite Index, centered on technology stocks, is expected to achieve significant growth by 2026. The primary driver of this potential upward trend stems from the rapid global adoption ...

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders ...

Before the trading day starts we bring you a digest of the key news and events that are likely to move markets. Today we look ...

Ripple CEO Brad Garlinghouse believes certain forces are preventing cryptocurrencies from gaining the same recognition as ...

Ooops... Something went wrong while loading this page.

The U.S. stock market's sharp drop on Oct. 10 generated a new McMillan volatility band (MVB) sell signal (marked with a green "S" on the chart). That market drop also increased realized volatility, so ...